What is Aisteth?
Aisteth is an AI-first company dedicated to making chronic disease screening cost-effective for primary care clinics. Their core innovation, AiSteth, is an AI-enabled smart stethoscope designed to screen, detect, and predict heart and lung disorders through advanced signal processing and machine learning capabilities. This technology aims to enhance diagnostic accuracy and accessibility at the foundational level of healthcare delivery.
How much funding has Aisteth raised?
Aisteth has raised a total of $1.5M across 1 funding round:
Series A
$1.5M
Series A (2024): $1.5M with participation from The Chennai Angels, Rainmatter Capital, and BiocytiH Foundation
Key Investors in Aisteth
The Chennai Angels
The Chennai Angels is an Indian angel investment group focused on funding early-stage startups, providing capital and mentorship to entrepreneurs across various sectors.
Rainmatter Capital
Rainmatter by Zerodha is an Indian fund supporting founders in fintech, climate, and health, offering capital and networks for long-term impact.
BiocytiH Foundation
BITS BioCyTiH Foundation fosters interdisciplinary cyber-physical systems through research, development, and startup incubation, particularly in biology, electronics, and computer science.
What's next for Aisteth?
With this major enterprise-level funding, Aisteth is poised for significant scaling and further development of its AI-driven diagnostic tools. The strategic investment will likely accelerate product refinement, expand market reach into more primary care clinics, and bolster research into predictive health analytics. This financing round signals strong investor confidence in Aisteth's mission to democratize early disease detection and improve patient outcomes globally.
See full Aisteth company page
